Article info
PDFCurrent controversy
Priority vaccination for mental illness, developmental or intellectual disability
- Correspondence to Nina Shevzov-Zebrun, Grossman School of Medicine, NYU Langone Health, New York, NY 10016-4576, USA; nsz220{at}nyumc.org
Citation
Priority vaccination for mental illness, developmental or intellectual disability
Publication history
- Received January 14, 2021
- Revised March 13, 2021
- Accepted March 21, 2021
- First published April 7, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (22 July 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Staff experiences of diabetes care in residential care facilities for people with severe disabilities in Denmark: a mixed-methods assessment of access to screening for diabetes complications
- Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK
- COVID-19 infection and outcomes in a population-based cohort of 17 203 adults with intellectual disabilities compared with the general population
- Case–control study to estimate odds of death within 28 days of positive test for SARS-CoV-2 prior to vaccination for residents of long-term care facilities in England, 2020–2021
- Hospitalisation rates for children with intellectual disability or autism born in Western Australia 1983–1999: a population-based cohort study
- Mortality in residential care facilities for people with disability: a descriptive cross-sectional analysis of statutory notifications in Ireland
- Influence of intellectual disability on exercise regulation: exploring verbal, auditory and visual guidance to contribute to promote inclusive exercise environments
- Request for euthanasia by a psychiatric patient with undetected intellectual disability
- Time-varying risk of death after SARS-CoV-2 infection in Swedish long-term care facility residents: a matched cohort study
- How can early COVID-19 vaccine campaigns in the US-affiliated Pacific Islands inform future vaccine efforts: a cross-sectional analysis